Currently out of the existing stock ratings of Edward White, 341 are a BUY (96.6%), 11 are a HOLD (3.12%), 1 are a SELL (0.28%).

Edward White

Work Performance Price Targets & Ratings Chart

Analyst Edward White, currently employed carries an average stock price target met ratio of 23.98% that have a potential upside of 44.1% achieved within 109 days. Previously, Edward White worked at HC WAINWRIGHT.

Edward White’s has documented 688 price targets and ratings displayed on 33 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on NYXH, Nyxoah at 13-Dec-2024.

Wall Street Analyst Edward White

Analyst best performing recommendations are on SBTX (SILVERBACK THERAPEUTICS ).
The best stock recommendation documented was for MRTX (MIRATI THER) at 11/15/2017. The price target of $17 was fulfilled within 1 day with a profit of $2.95 (21%) receiving and performance score of 209.96.

Average potential price target upside

LUMO Lumos Pharma CLVS Clovis Oncology CMRX Chimerix DVAX Dynavax Technologies GTHX G1 Therapeutics IFRX InflaRx N.V. INZY Inozyme Pharma  TGTX TG Therapeutics VALN Valneva SE ADR VYNT Vyant Bio XLRN Acceleron Pharma CORI Corium International KPTI Karyopharm Therapeutics PBYI Puma Biotechnology SNDX Syndax Pharmaceuticals SPPI Spectrum Pharmaceuticals ACET Adicet Bio AGLE Aeglea Bio Therapeutics CGEM Cullinan Oncology LLC GLYC GlycoMimetics SABS SAB Biotherapeutics BOLT Bolt Biotherapeutics CRIS Curis IKT Inhibikase Therapeutics  NYXH Nyxoah ALNA Allena Pharmaceuticals CCXI ChemoCentryx SBTX Silverback Therapeutics  IDYA Ideaya Biosciences LJPC La Jolla Pharmaceutical Co MRSN Mersana Therapeutics MRTX Mirati Ther TCON TRACON Pharmaceuticals

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$4.25

$-0.09 (-2.07%)

$4.25

1 months 10 days ago
(08-Nov-2024)

1/6 (16.67%)

$-0.09 (-2.07%)

148

Buy

$13

$8.66 (199.54%)

4 months 16 days ago
(02-Aug-2024)

0/1 (0%)

$11.13 (595.19%)

Buy

$10

$5.66 (130.41%)

$10

1 years 3 months 26 days ago
(22-Aug-2023)

1/4 (25%)

$7.03 (236.70%)

28

Hold

$7

$2.66 (61.29%)

$7

2 years 10 days ago
(08-Dec-2022)

2/4 (50%)

$2.8 (66.67%)

79

Buy

$26

2 years 1 months 4 days ago
(14-Nov-2022)

2/5 (40%)

$17.95 (222.98%)

182

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Edward White is most bullish on?

Potential upside of $37.07 has been obtained for SNDX (SYNDAX PHARMACEUTICALS)

Which stock is Edward White is most reserved on?

Potential downside of -$4.59 has been obtained for KPTI (KARYOPHARM THERAPEUTICS)

What Year was the first public recommendation made by Edward White?

On 2015

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?